What a nice day on Wall Street on Monday, reversing from Friday’s huge drop. It had an opening gap down, Nasdaq 100 going from 4660, and running up to 4772, more than 115 points from top to bottom. The S&P 500 went from under 2120 to 2163, in nice, 45-degree angles, but I would be careful on Tuesday.
EXACT Sciences Corporation (NASDAQ:EXAS) looks really good, up 24 cents, or 1.27%, to 19.07, on 3 million shares traded. It had a nice reversal off support, 50-day, lateral price support, going from 17.61 to 19.08, closing just a penny off the high on a nice reversal day. I want to see if it gets up to the 20.29 zone. If it gets to 20-20.05 we’re going to have a run-on. I’m looking for wave five, which could take this stock up substantially.
Exelixis Inc (NASDAQ:EXEL) looks great, up 42 cents, or 3.5%, to 12.40, on 4.3 million shares traded. on Monday I love the way this stock came down, held at the double top, consolidated with reversal day off the low, and basically tested the bottom of the channel. It could be spiking up towards 15 pretty shortly. Keep an eye on this one. It has 6 days to cover.
Nektar Therapeutics (NASDAQ:NKTR) is one of my favorite biotech’s this year. It was up 66 cents, or 3.56%, on 1.2 million shares traded on Monday. I really like the way it’s acting, even though it pulled back, but it snapped back from 18.58 to 19.32, and closed at the highs for the day going away. The volume was solid but not strong. The next target is 21 1/2, and then 23.
Puma Biotechnlgy (NYSE:PBYI) had a breakout day on Monday, up 4.92, or 8.35%, to 63.82, on 806,616 shares traded on Monday. It popped, consolidated, had a breakout day 3 weeks ago, and popped and ran. I expect the same with Monday’s breakout. I’m looking for 72, and then 74 as targets.
Stocks on the long side included Acacia Communications Inc (NASDAQ:ACIA), Ambarella Inc (NASDAQ:AMBA), Accelerate Diagnostics Inc (NASDAQ:AXDX), Bluebird bio Inc (NASDAQ:BLUE), Clovis Oncology Inc (NASDAQ:CLVS), Conns Inc (NASDAQ:CONN), Clayton Williams Energy Inc (NYSE:CWEI), Exact Sciences Corporation (EXAS), Exelixis, Inc. (EXEL), Gigamon Inc (NYSE:GIMO), Himax Technologies Inc (NASDAQ:HIMX), Momo Inc (NASDAQ:MOMO), NII Holdings Inc (NASDAQ:NIHD), Nektar Therapeutics (NKTR), NeoPhotonics Corporation (NYSE:NPTN), Novavax Inc (NASDAQ:NVAX), Puma Biotechnology, Inc. (PBYI), Resolute Energy Corp (NYSE:REN), Reata Pharmaceuticals Inc (NASDAQ:RETA), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Vuzix Corp Cmn Stk (NASDAQ:VUZI), Wynn Resorts Limited (NASDAQ:WYNN), and Xencor Inc (NASDAQ:XNCR).